Immunologic memory response induced by a meningococcal serogroup C conjugate vaccine using the P64k recombinant protein as carrier

FEMS Immunology and Medical Microbiology

Volumn 46, Issue 2, 2006, Pages 169-179

  Guirola, María ^a,b   Urquiza, Dioslaida ^a   Álvarez, Anabel ^a   Cannan Haden, Leonardo ^a   Caballero, Evelin ^a   Guillén, Gerardo ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b NONE   (Cuba)

Author keywords

Adoptive transfer; Carrier protein; Conjugate vaccine; Memory response; Neisseria meningitidis; P64k

Indexed keywords

BACTERIAL POLYSACCHARIDE; CARRIER PROTEIN; GLYCOCONJUGATE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MENINGOCOCCUS VACCINE; PROTEIN P64K; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BACTERICIDAL ACTIVITY; CELL ACTIVITY; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SCREENING; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; IMMUNOPROPHYLAXIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFER; MEMORY T LYMPHOCYTE; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL;

ADOPTIVE TRANSFER; ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BLOOD BACTERICIDAL ACTIVITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MICE; MICE, INBRED BALB C; NEISSERIA MENINGITIDIS; RATS; RECOMBINANT PROTEINS;

EID: 33645095182     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2005.00025.x     Document Type: Article

References (34)

1. Ahmad H Chapnick EK 1999 Conjugated polysaccharide vaccines Infect Dis Clin North Am 13 113 133
2. Artenstein MS Gold R Zimmerly JG Wyle FA Schneider H Harkins C 1970 Prevention of meningococcal disease by group C polysaccharide vaccine N Engl J Med 282 417 420
3. Borrow R Richmond P Kaczmarski A et al 2000 Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine FEMS Immunol Med Microbiol 28 79 85
4. Cadoz M 1998 Potential and limitations of polysaccharide vaccines in infancy Vaccine 16 1391 1395
5. Carmenate T Canaan L Alvarez A Delgado M Gonzalez S Menendez T Rodes L Guillen G 2004 Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates FEMS Immunol Med Microbiol 40 193 199
6. Carmenate T Guirola M Alvarez A Canaan L Gonzalez S Caballero E Menéndez T Guillén G 2005 Memory response generated in Cercophitecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine FEMS Immunol and Medical Microbiol 43 133 140
7. Dagan R Eskola J Leclerc C Leroy O 1998 Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants Infect Immun 66 2093 2098
8. Fattom A Cho YH Chu C Fuller S Fries L Naso R 1999 Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines Vaccine 17 126 133
9. Garner C Pier G 1989 Immunologic considerations for the development of conjugate vaccines Conjugate vaccines vol. 10 Cruise JM Lewis RE Jr. ed), pp. 11 17 Karger Basel, Switzerland
10. Gheesling LL Carlone GM Pais LB et al 1994 Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay J Clin Microbiol 32 1475 1482
11. González G Pardo O Sánchez B et al 1997 Induction of immune recognition of self epidermal growth factor-II characterization of the antibody response and the use of a fusion protein Vaccine Res 6 91 100
12. González S Alvarez A Caballero E Vina L Guillen G Silva R 2000a P64k meningococcal protein as immunological carrier for weak immunogens Scand J Immunol 52 113 116
13. González S Vina L Nazabal C Chinea G Caballero E Musacchio A 2000b B-cell epitope mapping of the Neisseria meningitidis P64k protein using overlapping peptides Biotechnol Appl Biochem 32 1 8
14. Guillén G Duarte C Alvarez A et al 1996 System for the expression of heterolous antigens as fusion proteins. PCT Patent WO9726359
15. Guillen G Alvarez A Silva R et al 1998 Expression in Escherichia coli of the lpdA gene, protein sequence analysis and immunological characterization of the P64k protein from Neisseria meningitidis Biotechnol Appl Biochem 27 Part 189 196
16. Guttormsen HK Sharpe A Chandraker A Brigtsen A Sayegh M Kasper DL 1999 Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines Infect Immun 6375 6384
17. Guttormsen HK Wetzler LM Finberg RW Kasper DL 1998 Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model Infect Immun 66 2026 2032
18. Kundig TM Bachmann MF Oehen S Hoffmann UW Simard JJ Kalberer CP Pircher H Ohashi PS Hengartner H Zinkernagel RM 1996 On the role of antigen in maintaining cytotoxic T-cell memory Proc Natl Acad Sci USA 93 9716 9723
19. Li de la Sierra I Pernot L Prange T Saludjian P Schiltz M Fourme R Padron G 1997 Molecular structure of the lipoamide dehydrogenase domain of a surface antigen from Neisseria meningitidis J Mol Biol 269 129 141
20. MacDonald NE Halperin SA Law BJ Danzig LE Granoff DM 2000 Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine? JAMA 283 1826 1827
21. MacLennan J Obaro S Deeks J Williams D Pais L Carlone G Moxon R Greenwood B 1999 Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunization during early childhood Vaccine 17 3086 3093
22. Maslanka SE Gheesling LL Libutti DE et al 1997 Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group Clin Diagn Lab Immunol 4 156 167
23. Maslanka SE Tappero JW Plikaytis BD et al 1998 Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine Infect Immun 66 2453 2459
24. Mitchison N 1971 The carrier effect in the secondary response to hapten-protein conjugates. I. Measurements of the effect with transferred cells and objections to the local environment hypothesis Eur J Immunol 1 10 17
25. Perez A Dickinson F Cinza Z et al 2001 Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers Biotechnol Appl Biochem 34 121 125
26. Richmond P Borrow R Miller E Clark S Sadler F Fox A Begg N Morris R Cartwright K 1999a Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory J Infect Dis 179 1569 1572
27. Richmond P Goldblatt D Fusco PC Fusco JD Heron I Clark S Borrow R Michon F 1999b Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults Vaccine 18 641 646
28. Richmond P Kaczmarski E Borrow R Findlow J Clark S McCann R Hill J Barker M Miller E 2000 Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine J Infect Dis 181 761 764
29. Richmond P Borrow R Goldblatt D Findlow J Martin S Morris R Cartwright K Miller E 2001 Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers J Infect Dis 183 160 163
30. Saukkonen K 1988 Experimental meningococcal meningitis in the infant rat Microb Pathog 3 203 211
31. Schutze MP Leclerc C Jolivet M Audibert F Chedid L 1985 Carrier-induced epitopic suppression, a major issue for future synthetic vaccines J Immunol 135 2319 2322
32. Silva R Selman M Guillen G et al 1992 Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations. European Patent Application EP 0474313 A2.
33. Silva R Menendez T Alonso LM et al 1999 Characterisation of the lpdA gene from Neisseria meningitidis by polymerase chain reaction, restriction fragment length polymorphism and sequencing FEMS Microbiol Lett 174 191 199
34. Wessels MR Paoletti LC Kasper DL DiFabio JL Michon F Holme K Jennings 1990 Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus J Clin Invest 86 1428 1433